Clinical-stage biotechnology company Checkmate Pharmaceuticals Inc. reported data from its Phase 1b trial evaluating the combination of vidutolimod and pembrolizumab for the treatment …
Regeneron Pharmaceuticals Inc. reported positive data from its Phase 3 trial evaluating REGEN-COV in recently infected asymptomatic COVID-19 patients.
Minimally invasive medical devices provider AngioDynamic Inc has submitted a 510(K) application for its AlphaVac System to the U.S.
Search company Elastic N.V.
Canopy Growth Corp. has agreed to acquire The Supreme Cannabis Company for a total consideration of $435 million.
Technology-enabled services platforms provider HealthEquity has agreed to acquire Further for a consideration of $500 million. The latter provides health savings account (HSA) …
Clinical-stage biopharmaceutical company Syndax Pharmaceuticals, Inc. has received Orphan Drug Designation for axatilimab from the U.
Specialty pharmaceutical company KemPharm, Inc. amended its collaboration and licensing agreement with an affiliate of Gurnet Point Capital (GPC).
Semiconductor company Analog Devices is collaborating with MDA on a beam-forming integrated circuit (BFIC). The BFIC will be used in MDA’s phased array …
Cannabis products provider The Valens Company Inc. has entered into a supply and distribution agreement with Manitoba Liquor and Lotteries Corporation.